Digital Clinical Trials Market Analysis and Forecast to 2030 Report

Description

Digital Clinical Trials Market Report Highlights:

Key Segments: Digital Wearable Devices, AI-enabled Devices, Decentralized/Virtual Clinical Trials, Hybrid Clinical Trials

Key Comeptitors: PPD, Inc., Signant Health, HumanFirst, IQVIA, Deloitte

Geographies: USA, China, UK, Japan, Germany, France, Italy, Spain, The Netherlands, Canada, India, South Korea, Australia, New Zealand, Middle East, Africa, South and Central America

Historical Data: 2018-2020

Forecasting Period: 2021-2030

Research Methods: Primary Research, Secondary Research, COVID-19 Impact Analysis

Forecast Methods: Market Research, Trend Projections, Panel Consensus, Historical Analogy

Pages and Exhibits: 130+ pages, 60+ Statistical Tables, 25+ Analysis Figures

Market Currency: US Dollar ($)

Report Language: English

Report Format: Online, Downloadable PDF, Excel

Available Customizations: Provider Side Report, Thought Leadership Report

Digital Clinical Trials Market Definition:

Digital Clinical Trials product manufacturers are helping pharmaceutical companies to assess the clinical trials remotely by providing innovative digital aids such as wearable devices, AI-enabled devices, and mobile health applications, among others.

Digital Clinical Trials Market, by Product	Digital Wearable Devices AI-Enabled Devices Health Apps Software
Digital Clinical Trials Market, by Type	Decentralized/Virtual Clinical Trials Hybrid Clinical Trials
Digital Clinical Trials Market, by Phase	Phase I Phase II Phase III Phase IV
Digital Clinical Trials Market, by End User	Pharmaceutical Companies Biotechnology Companies Contract Research Organizations (CROs) Others
Digital Clinical Trials Market Key Competitors	PPD, Inc. Signant Health HumanFirst CRFweb. Data Management 365 IQVIA IBM Deloitte Others
Digital Clinical Trials Market, By Geography	North America USA Canada South and Central America Europe Germany France U.K. Italy Spain The Netherlands Rest of Europe Asia-Pacific China Japan India South Korea Australia New-Zealand Rest of Asia-Pacific Middle East & Africa

 

Table of Content and Chapter Description:

1. Digital Clinical Trials Market Summary

This section includes summary of whole report. It majorly includes brief analysis of market numbers, various forecast factors and market dynamics such as drivers, restraints, opportunities, and key trends. In addition to this, this section also talks about leading players operating in the market.

2. Report Inclusion & Exclusion

This section provides brief idea about the factors included in the study, along with the factors which are not considered in the study. It helps the reader to have better understanding of the provided information.

3. Market Dynamics

This section provides detailed analysis of drivers, restraints, opportunities, and threats which have significant impact on the growth of the market. It also includes key trends influencing the market growth and demand.

4. Key Market Insights

This section majorly includes analysis of micro and macro-economic indicators that would have direct or indirect impact on the market growth. This section also includes pricing analysis, product pipeline analysis, PORTER’S five forces analysis, PESTLE analysis, funding analysis, among others.

5. COVID-19 Impact Analysis

This section provides detailed analysis of pre and post COVID-19 pandemic impact on the market. The section provides effect of COVID-19 during 2020 and 2021, and also provides recovery scenario. In addition to this, it also analyzes impact of vaccination drive on the market recovery.

6. Digital Clinical Trials Market Analysis and Forecast to 2030, by Product

This section provides detailed country level market estimations and analysis of Digital Clinical Trials, by Product. The segments majorly include Digital Wearable Devices, AI-Enabled Devices, Health Apps, and Software

7. Digital Clinical Trials Market Analysis and Forecast to 2030, by Type

This section provides detailed country level market estimations and analysis of Digital Clinical Trials, by Type. The segments majorly include Decentralized/Virtual Clinical Trials, and Hybrid Clinical Trials.

8. Digital Clinical Trials Market Analysis and Forecast to 2030, by Phase

This section provides detailed country level market estimations and analysis of Digital Clinical Trials, by Phase. The segments majorly include Phase I, Phase II, Phase III, and Phase IV.

9. Digital Clinical Trials Market Analysis and Forecast to 2030, by End User

This section includes revenue estimation, forecast and detailed analysis of Digital Clinical Trials based on End-Users at country level. The segments consist of Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), and Others.

10. Digital Clinical Trials Market Analysis and Forecast to 2030, by Geography

This section includes segmental level revenue estimation, forecast and detailed analysis of major geographies including North America, South and Central America, Europe, Asia-Pacific, and Middle East & Africa.

11. Competition Analysis

This section provides detailed analysis of key companies operating in this market. It includes, products/services ranking, market positioning, company competition matrix, impact analysis, market share analysis, and each company’s overviews.

12. Appendix
    • Digital Clinical Trials Market: Research Methodology

This section includes detailed explanation of various techniques used during market estimation. It majorly involves primary and secondary research. Primary research involves interviews with industry personals and key opinion leaders from respective sectors, while secondary research includes data gathering through internet search, databases such as Bloomberg, FactSet, among others. In addition to this, the section also involves explanation of data forecast models used during the study.

• • Appendix
  • Abbreviations